Comparison of Formulas for Calculating Low-Density Lipoprotein Cholesterol in General Population and High-Risk Patients with Cardiovascular Disease

被引:23
|
作者
Choi, Hansol [1 ,3 ]
Shim, Jee-Seon [3 ]
Lee, Myung Ha [2 ,3 ]
Yoon, Young Mi [3 ]
Choi, Dong Phil [3 ]
Kim, Hyeon Chang [2 ,3 ]
机构
[1] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea
关键词
Low-density lipoprotein cholesterol; Cholesterol; Triglyceride; Friedewald formula; DIRECT HOMOGENEOUS ASSAY; LDL-CHOLESTEROL; FRIEDEWALD FORMULA; DIABETES-MELLITUS; MANAGEMENT; REGRESSION; EQUATIONS; VALUES;
D O I
10.4070/kcj.2016.46.5.688
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Low-density lipoprotein cholesterol (LDL-C), an established cardiovascular risk factor, can be generally determined by calculation from total cholesterol, high-density lipoprotein cholesterol, and triglyceride concentrations. The aim of this study was to compare LDL-C estimations using various formulas with directly measured LDL-C in a community-based group and hospital-based group among the Korean population. Subjects and Methods: A total of 1498 participants were classified into four groups according to triglyceride concentrations as follows: <100, 100-199, 200-299, and >= 300 mg/dL. LDL-C was calculated using the Friedewald, Chen, Vujovic, Hattori, de Cordova, and Anandaraja formulas and directly measured using a homogenous enzymatic method. Pearson's correlation coefficients, intraclass correlation coefficients (ICC), Passing & Bablok regression, and Bland-Altman plots were used to evaluate the performance of six formulas. Results: The Friedewald formula had the highest accuracy (ICC=0.977; 95% confidence interval 0.974-0.979) of all the triglyceride ranges, while the Vujovic formula had the highest accuracy (ICC=0.876; 98.75% confidence interval 0.668-0.951) in people with triglycerides >= 300 mg/dL. The mean difference was the lowest for the Friedewald formula (0.5 mg/dL) and the percentage error was the lowest for the Vujovic formula (30.2%). However, underestimation of the LDL-C formulas increased with triglyceride concentrations. Conclusion: The accuracy of the LDL-C formulas varied considerably with differences in triglyceride concentrations. The Friedewald formula outperformed other formulas for estimating LDL-C against a direct measurement and the Vujovic formula was suitable for hypertriglyceridemic samples; it could be used as an alternative cost-effective tool to measure LDL-C when the direct measurement cannot be afforded.
引用
收藏
页码:688 / 698
页数:11
相关论文
共 50 条
  • [41] CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL &gt;100/70 MG/DL AT BASELINE
    Robinson, Jennifer
    Schiele, Francois
    Laufs, Ulrich
    Lettino, Maddalena
    Valcheva, Velichka
    Guillonneau, Sophie
    Iorga, Serban R.
    Narcisse, Nadege
    Fox, Keith
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1712 - 1712
  • [42] Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients
    Foody, JoAnne M.
    Sajjan, Shiva G.
    Hu, X. Henry
    Ramey, Dena R.
    Neff, David R.
    Tershakovec, Andrew M.
    Tomassini, Joanne E.
    Wentworth, Chuck
    Tunceli, Kaan
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (02) : 126 - 132
  • [43] Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol
    deGoma, Emil M.
    Leeper, Nicholas J.
    Heidenreich, Paul A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) : 49 - 55
  • [44] Low high-density lipoprotein cholesterol disorders and cardiovascular risk: contribution of associated low-density lipoprotein subclass abnormalities
    Rosenson, RS
    CURRENT OPINION IN CARDIOLOGY, 2005, 20 (04) : 313 - 317
  • [45] Total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol in atherosclerosis cardiovascular disease and cancer in Chinese male
    Guan, X. M.
    Yang, X. L.
    Han, X.
    Yang, Y. H.
    Liu, Y.
    Li, H. H.
    Zhan, S. Y.
    Wu, S. L.
    Xia, Y. L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 724 - 725
  • [46] Interventions to Lower Low-Density Lipoprotein Cholesterol and Cardiovascular Risk Reply
    Silverman, Michael G.
    Im, Kyungah
    Sabatine, Marc S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 440 - 440
  • [47] The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk
    Higashioka, Mayu
    Sakata, Satoko
    Honda, Takanori
    Hata, Jun
    Shibata, Mao
    Yoshida, Daigo
    Goto, Kenichi
    Kitazono, Takanari
    Osawa, Haruhiko
    Ninomiya, Toshiharu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (01) : 79 - 89
  • [48] Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care
    Bilgic, Selin
    Sniderman, Allan D.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (01) : 49 - 53
  • [49] Contemporary lipid clinic and achievements in low-density lipoprotein-cholesterol reductions in very high-risk patients
    Larsen, Jens V.
    Martinsen, Morten H.
    Mortensen, Martin B.
    Klausen, Ib C.
    Hedegaard, Berit S.
    DANISH MEDICAL JOURNAL, 2021, 68 (01):
  • [50] Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: Comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial
    Insull, William, Jr.
    Ghali, Jalal K.
    Hassman, David R.
    Ycas, Joseph W.
    Gandhi, Sanjay K.
    Miller, Elinor
    MAYO CLINIC PROCEEDINGS, 2007, 82 (05) : 543 - 550